Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Gene Therapy00:59

Gene Therapy

25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
What is Genetic Engineering?00:49

What is Genetic Engineering?

74.1K
Overview
74.1K
The Central Dogma01:20

The Central Dogma

21.7K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
21.7K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
CRISPR01:59

CRISPR

51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dopamine receptors in ocular surface biology: Current evidence and future directions.

Indian journal of ophthalmology·2026
Same author

Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy.

Indian journal of ophthalmology·2026
Same author

Long-term Outcomes of the Management of Chronic Refractory Ocular Allergy Using Allergen Immunotherapy.

Cornea·2026
Same author

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Investigative ophthalmology & visual science·2026
Same author

Biological cleansing: Toward improving ocular surface surgical outcomes.

Indian journal of ophthalmology·2026
Same author

Sesamol reprograms mitochondrial dysfunction and metabolic signaling to rescue endothelial degeneration in Fuchs' endothelial corneal dystrophy.

Free radical biology & medicine·2026

相关实验视频

Updated: Jul 2, 2025

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.6K

基因治疗研究在印度的最新发展.

Ruchita Selot1, Arkasubhra Ghosh

  • 1GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru 560099, India.

Journal of biosciences
|February 22, 2024
PubMed
概括

基因疗法为遗传遗传性疾病提供了有前途的治疗方法,像腺相关病毒 (AAV) 这样的病毒载体显示出显著的潜力. 印度正在推进基因治疗研究和临床试验,解决挑战,使其庞大的罕见疾病人口受益.

科学领域:

  • 分子生物学分子生物学
  • 遗传学 是一个遗传学.
  • 生物技术是生物技术.

背景情况:

  • 遗传遗传性疾病是渐进的,往往导致严重的器官功能障碍或死亡,超过95%的人缺乏永久的治疗选择.
  • 基因疗法涉及基因修复,替代,抑制或编辑,为治疗全球数以百万计的罕见遗传疾病提供了一个有希望的分子方法.
  • 病毒载体,特别是腺相关病毒 (AAV) 和晶状病毒,由于其效率,越来越多地被用于基因疗法临床试验.

研究的目的:

  • 概述基因疗法研究,监管流程和印度的临床试验启动.
  • 将印度的基因疗法进步与全球发展联系起来.
  • 突出印度基因疗法领域正在进行的研究,产品制造和社区倡议.

主要方法:

  • 审查当前的基因疗法研究和临床试验数据,专注于病毒载体应用.
  • 分析影响印度基因疗法发展和采用的因素,包括基础设施和投资.
  • 讨论印度基因治疗临床试验的监管框架和指导方针.

主要成果:

  • 腺关联病毒 (AAV) 介导的基因疗法在临床试验中已经证明了对各种疾病的高潜力.
  • 显著的金融投资,技术开发和训练有素的人力对于基因治疗产品的制造和批准至关重要.

更多相关视频

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

1.9K
Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications
03:52

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

2.6K

相关实验视频

Last Updated: Jul 2, 2025

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.6K
Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

1.9K
Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications
03:52

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

2.6K
  • 印度正在增加其基因疗法开发,受到全球批准和日益增长的罕见疾病意识的刺激,尽管有历史性的基础设施挑战.
  • 结论:

    • 基因疗法对治疗印度大量患者群体中罕见的遗传疾病具有巨大的前景.
    • 解决基础设施,患者数据和投资方面的挑战是推动印度基因疗法的关键.
    • 医学界,患者团体和监管机构之间的协作努力对于成功实施基因治疗至关重要.